Production of 40 liters of high titer clinical grade lentiviral vector stock. POP 1 year.

Ended Purchase Order Awarded Last action

Contract number
HHSN261201600746P
Awardee
Awarding agency
Obligated
$198,308

Award facts

Opportunity
  • N02CO6271278 Solicitation number
  • N02CO62712-78 Award Notice · Posted Sep 11, 2016
Contract value 100% obligated
$198,307.85 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Indianapolis, IN 46202, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 $0
Original award $198,308

About this award

The National Cancer Institute awarded a purchase order to Trustees of Indiana University for the production of 40 liters of high-titer clinical-grade lentiviral vector stock on September 23, 2016, with a ceiling value of $198,307.85 and firm fixed pricing. Performance is located in Indianapolis, Indiana. The period of performance is one year, with an ultimate completion date of April 30, 2019. The award includes a modification to modify the terms and conditions.

Quick answers

Who was awarded contract HHSN261201600746P?

HHSN261201600746P was awarded to Trustees Of Indiana University by National Cancer Institute (National Institutes of Health) on September 23, 2016.

How much is contract HHSN261201600746P worth?

The government has obligated $198,308 on HHSN261201600746P.

Was contract HHSN261201600746P competed?

The extent of competition for HHSN261201600746P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award